Bilha Willner
YOU?
Author Swipe
View article: Aptamer‐Modified Homogeneous Catalysts, Heterogenous Nanoparticle Catalysts, and Photocatalysts: Functional “Nucleoapzymes”, “Aptananozymes”, and “Photoaptazymes”
Aptamer‐Modified Homogeneous Catalysts, Heterogenous Nanoparticle Catalysts, and Photocatalysts: Functional “Nucleoapzymes”, “Aptananozymes”, and “Photoaptazymes” Open
Conjugation of aptamers to homogeneous catalysts (“nucleoapzymes”), heterogeneous nanoparticle catalysts (“aptananozymes”), and photocatalysts (“photoaptazymes”) yields superior catalytic/photocatalytic hybrid nanostructures emulating func…
View article: Frontispiece: Bioinspired Artificial Photosynthetic Systems
Frontispiece: Bioinspired Artificial Photosynthetic Systems Open
Inspired by the natural photosynthetic apparatus, research efforts are directed towards the development of artificial photosynthetic model systems. This perspective introduces recent advances in developing photobioelectrochemical cells bas…
View article: Mimicking Functions of Native Enzymes or Photosynthetic Reaction Centers by Nucleoapzymes and Photonucleoapzymes
Mimicking Functions of Native Enzymes or Photosynthetic Reaction Centers by Nucleoapzymes and Photonucleoapzymes Open
The covalent linkage of catalytic units to aptamer sequence-specific nucleic acids exhibiting selective binding affinities for substrates leads to functional scaffolds mimicking native enzymes, nucleoapzymes. The binding of the substrates …
View article: Thrombin Aptamer-Modified Metal–Organic Framework Nanoparticles: Functional Nanostructures for Sensing Thrombin and the Triggered Controlled Release of Anti-Blood Clotting Drugs
Thrombin Aptamer-Modified Metal–Organic Framework Nanoparticles: Functional Nanostructures for Sensing Thrombin and the Triggered Controlled Release of Anti-Blood Clotting Drugs Open
This paper features the synthesis of thrombin-responsive, nucleic acid-gated, UiO-68 metal–organic framework nanoparticles (NMOFs) loaded with the drug Apixaban or rhodamine 6G as a drug model. Apixaban acts as an inhibitor of blood clots …